It has not ICD10 code..
Conditions
Interventions
Intervention 1: Test group: subjects in test group will recievel 6.0 g/day fish-oil supplementation in capsules (American,Vita Cost) containing 3.6 g of n-3 polyunsaturate fatty acids containing 2400
Test group: subjects in test group will recievel 6.0 g/day fish-oil supplementation in capsules (American,Vita Cost) containing 3.6 g of n-3 polyunsaturate fatty acids containing 2400 mg of EPA and 12
Placebo group: Subjects in placebo group will receive 6gr/day placebo capsules containing mineral oil purchased from Zahravi Pharmaceutical Inc. (Iran) for 4 weeks. Moreover, all subjects will experie
Sponsors
Vice chancellor for research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: The main inclusion criteria: 18 to 30 years of age, non-smoking, agree to avoid sea foods throughout the study,sign informed consent. The main exclusion criteria: History of cardiovascular disease or diabetes, allergy to fish oil, appearance of intestinal side effects such as chronic and acute abdominal pains, diarrhea, and vomiting, acute fever and headache, consumption of anti-coagulation drugs such as aspirin or warfarin.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Age. Timepoint: prior to study. Method of measurement: Questionnaire.;Height. Timepoint: prior to study. Method of measurement: meter.;Weight. Timepoint: prior to study. Method of measurement: balance.;Lean body mass. Timepoint: prior to study. Method of measurement: InBody-520 instrument.;Blood fat. Timepoint: prior to study. Method of measurement: laboratory.;Maximal oxygen uptake. Timepoint: prior to study. Method of measurement: CASMED instrument. | — |
Secondary
| Measure | Time frame |
|---|---|
| TNF-alpha level. Timepoint: 48 hr before and after study period. Method of measurement: ELISA.;IL-1beta. Timepoint: 48 hr before and after study period. Method of measurement: ELISA.;IL-6 level. Timepoint: 48 hr before and after study period. Method of measurement: ELISA.;IFN-gamma level. Timepoint: 48 hr before and after study period. Method of measurement: ELISA.;IL-4 level. Timepoint: 48 hr before and after study period. Method of measurement: ELISA.;IL-10 level. Timepoint: 48 hr before and after study period. Method of measurement: ELISA.;Th1 frequency. Timepoint: 48 hr before and after study period. Method of measurement: Flow cytometry.;Th2 frequency. Timepoint: 48 hr before and after study period. Method of measurement: Flow cytometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarhad Jadidi-Niaragh
Tehran University of Medical Sciences
Outcome results
None listed